Increased circulating leptin levels in patients with CAD have been associated with short-term occurrence of cardiac remodelling, impaired diastolic function, cardiac heart failure, cardiac death, acute coronary syndrome, and stroke [57,58,59,60]. This evidence concerns the gene LEP and coronary artery disorder.